NASDAQ:IOBT IO Biotech Q3 2024 Earnings Report $1.45 +0.02 (+1.40%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast IO Biotech EPS ResultsActual EPS-$0.36Consensus EPS -$0.29Beat/MissMissed by -$0.07One Year Ago EPSN/AIO Biotech Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AIO Biotech Announcement DetailsQuarterQ3 2024Date11/12/2024TimeBefore Market OpensConference Call DateTuesday, November 12, 2024Conference Call Time7:00AM ETUpcoming EarningsIO Biotech's Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K) IO Biotech Earnings HeadlinesIOBT IO Biotech, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comIO Biotech Regains Nasdaq Compliance with Stock PriceJune 4, 2025 | msn.comThis Cold War “Accident” Could Unleash New $100 Trillion AI BoomObscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.July 8 at 2:00 AM | Brownstone Research (Ad)IO Biotech files for the sale of up to 5.6M shares of common stock for holdersMay 23, 2025 | msn.comIO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare ConferenceMay 20, 2025 | globenewswire.comIO Biotech price target raised to $14 from $12 at H.C. WainwrightMay 15, 2025 | finance.yahoo.comSee More IO Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like IO Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IO Biotech and other key companies, straight to your email. Email Address About IO BiotechIO Biotech (NASDAQ:IOBT) (NASDAQ: IOBT) is a clinical‐stage immuno‐oncology company focused on harnessing the body’s immune system to fight cancer. The company’s core mission is to develop novel peptide‐based vaccines and immunotherapies that target immune checkpoints and tumor‐associated antigens. By leveraging proprietary platforms, IO Biotech aims to deliver treatments that elicit robust, durable immune responses against a range of solid tumors. At the center of IO Biotech’s pipeline is IO102-IO103, a PD-L1 targeting peptide vaccine designed to enhance the efficacy of checkpoint inhibitors in patients with advanced melanoma. This lead candidate is being tested in combination with established PD-1 therapies to improve response rates and extend progression-free survival. In addition to IO102-IO103, the company is advancing next-generation vaccine candidates against colorectal, prostate and other solid tumors, as well as exploring combination strategies with targeted therapies and novel adjuvants. Founded in 2014 as a spin-out from the University of Copenhagen, IO Biotech is headquartered in Copenhagen, Denmark, with a subsidiary office in New York to support its North American clinical and regulatory efforts. The company’s scientific leadership includes Jacob E. Simonsen as Chief Executive Officer, Charlotte Eide Fredericksen as Chief Medical Officer and Peter Hall as Chief Technical Officer. Their combined expertise spans immunology, clinical development and pharmaceutical manufacturing. IO Biotech maintains strategic collaborations with academic institutions and contract research organizations across Europe and North America. As it advances its clinical programs, the company continues to expand its manufacturing capabilities and regulatory footprint, positioning itself to address significant unmet needs in oncology through innovative immunotherapeutic solutions.Written by Jeffrey Neal JohnsonView IO Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs Upcoming Earnings Bank of America (7/14/2025)America Movil (7/15/2025)Bank of New York Mellon (7/15/2025)BlackRock (7/15/2025)Citigroup (7/15/2025)JPMorgan Chase & Co. (7/15/2025)Progressive (7/15/2025)Charles Schwab (7/15/2025)UnitedHealth Group (7/15/2025)Wells Fargo & Company (7/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
